dosing difference between semaglutide and tirzepatide 🧬 SEMAGLUTIDE vs TIRZEPATIDE vs RETATRUTIDE 🧬 Understanding the difference Switching from Semaglutide to Tirzepatide:

Whatever your reason is for requesting to switch treatments, your clinician can support you and make sure you know exactly what changing medications will involve

WADA 2026 Prohibited List Status (Section S0) BPC-157 is named explicitly on the World Anti-Doping Agency 2025 and 2026 Prohibited Lists under section S0 (Non-Approved Substances), prohibited at all times in and out of competition

If you have doubts about the treatment or want more information about your medicine or the monitoring procedure, do ask the doctor or nurse

95% medication adherence in the first month 84% of prescribed patients engage with in-app content 56% use Med Tracker (where side effects can also be tracked) 56% engage in meal logging, with an average of 35 meals logged in the first month Patients log weight 1-2 times per week, on average, over the first 8 weeks of treatment Patients use Noom Move workouts an average of 6.9 times in the first month 45% engage with side-effect support in Nooms "Success Kit" Noom appreciates the potential of the new PDURS framework because it provides a way to put a software product on the drug label in an evidence-based way

Dosage adjustments are only required in patients with severe renal insufficiency